Pooled across 24 studies and 1,032 patients, GLP-1 RAs produced fat-preferential weight loss at every time point
Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nvoa F, et al
This study aimed to investigate whether Vutiglabridin, a novel oral small-molecule anti-obesity drug, complements GLP-1 RAs to enhance therapeutic efficacy by selectively reducing fat mass and achieving normal body composition
Hypoxia reduces the osteogenic differentiation of peripheral blood mesenchymal stem cells by upregulating Notch-1 expression
February 2026 Owen Mumford Enhances Unifine Pentips Range Owen Mumford expanded its Unifine Pentips pen needle portfolio with improved ultra-thin wall technology and optimized needle geometry to reduce injection force and enhance patient comfort for diabetes management
Theres no change to how you take your treatment